Shopping Cart

Remove All
Your shopping cart is currently empty

Proceed to checkout Continue shopping

Filter

Applied FilterClear all

By Target

CGRP Receptor
(1)
Potassium Channel
(1)
Others
(2)

Filter

Search Result

Results for "

bhv 3000

" in TargetMol Product Catalog

Inhibitors & Agonists
3

Rimegepant

BMS-927711, BMS927711, BMS 927711, BHV-3000

T46101289023-67-1

Rimegepant (BMS 927711) is a highly potent, oral calcitonin gene-related peptide (CGRP) receptor antagonist with a Ki value of 0.027 nM.

CGRP Receptor

In Stock

Size

QTY

Cited

(±)-C3001a

Cyclopentanecarboxylic acid, 3-[[[4-(6-methyl-2-benzothiazolyl)phenyl]amino]carbonyl]-, 3-[[[4-(6-Methyl-2-benzothiazolyl)phenyl]amino]carbonyl]cyclopentanecarboxylic acid, (RS)-C3001a

T719551374325-56-0

(±)-C3001a is the racemic mixture of C3001a (CAS: 2415154-29-7). C3001a is a selective activator of the TREK channel within the two-pore-domain potassium channel (K2P) family. C3001a specifically binds to a cryptic site formed by P1 and TM4 in TREK-1, thereby promoting the selective regulation of TREK-1 activity. C3001a targets TREK channels in the peripheral nervous system, reducing the excitability of pain-sensing neurons.

Others Potassium Channel

$293

In Stock

Size

QTY

Rimegepant sulfate hydrate

T708371374024-48-2

Rimegepant, also known as BMS-927711 and BHV-3000, is a potent, selective, competitive, and orally active calcitonin gene-related peptide (CGRP) antagonist in clinical trials for treating migraines. Rimegepant has shown in vivo efficacy without vasoconstriction effect. BMS-927711 is superior to placebo at several different doses (75 mg, 150 mg, and 300 mg) and has an excellent tolerability profile.

Others

$2,870

10-14 weeks

Size

QTY

Go to page 1

Page of

Product Comparison

Product
Bioactive
Species
Expression System
Tag
Accession Number
Amino Acid
Construction
Molecular Weight
Endotoxin
Formulation
Reconstitution
Stability & Storage
Shipping
Research Background
Size